Assobiotec - English version

12 May 2022

Assobiotec and Campus Biotech Digital together signed the agreement for improving and developing skills for biological medical product

An opportunity for reskilling and upskilling employees expertise and young graduateds competences

02 May 2022

"The NASDAQ IPO Path for Italian Life Science Companies", the webinar on 5 May 5.30 pm

The aim of the webinar is to provide an overview of the challenges and opportunities for companies that want to prepare for the listed market, with a focus on the Life Sciences world.

28 March 2022

Diadem announces firts closing of €10 million equity financing for its predict prognostic blood test for Alzheimer's disease

Diadem SpA, a company developing the first blood-based test for the early prediction of Alzheimer’s disease, announced the closing of the first tranche of a €10 million equity financing. The financing round is led by new investor CDP Venture Capital and existing investor Panakès Partners. The new funding follows the announcement earlier this month by Diadem and the European Investment Bank (EIB) that EIB has granted Diadem a €7.5 million venture loan.

22 February 2022

EryDel Appoints Thomas Sabia as Chief Commercial Officer

EryDel SpA announced the appointment of Thomas Sabia as Chief Commercial Officer. In this role, he will join EryDel’s experienced team to help the company navigate and execute its commercial strategy, following the success of the company’s Phase III study for ataxia telangiectasia (AT).

01 February 2022

BIO-Europe Spring® 2022 Digital - 16th Annual International Partnering Conference

March 28–31, 2022, Delivered Digitally the event for reconnecting and facilitating global partnerships

14 January 2022

Axxam announces the merger of its two German subsidiaries into Axxam GmbH

Axxam announced the merger of its two subsidiaries located in Germany. The decision is in line with the strategy to strengthen presence and investments in Germany and to offer to the several clients and partners integrating capacity and capabilities in early discovery research.

Go to the

News

Assobiotec and Campus Biotech Digital together signed the agreement for improving and developing skills for biological medical product

"The NASDAQ IPO Path for Italian Life Science Companies", the webinar on 5 May 5.30 pm

Diadem announces firts closing of €10 million equity financing for its predict prognostic blood test for Alzheimer's disease

EryDel Appoints Thomas Sabia as Chief Commercial Officer

BIO-Europe Spring® 2022 Digital - 16th Annual International Partnering Conference

Axxam announces the merger of its two German subsidiaries into Axxam GmbH

Partner

Where to find us